• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源腺苷 A 受体-G 信号复合物的冷冻电镜结构。

Cryo-EM structure of the human adenosine A receptor-G signaling complex.

机构信息

Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.

iHuman Institute, ShanghaiTech University, Shanghai 201210, China.

出版信息

Sci Adv. 2022 Dec 23;8(51):eadd3709. doi: 10.1126/sciadv.add3709.

DOI:10.1126/sciadv.add3709
PMID:36563137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9788782/
Abstract

The human adenosine A receptor (AR) is a class A G protein-coupled receptor that is involved in several major physiological and pathological processes throughout the body. AR recognizes its ligands adenosine and NECA with relatively low affinity, but the detailed mechanism for its ligand recognition and signaling is still elusive. Here, we present two structures determined by cryo-electron microscopy of AR bound to its agonists NECA and BAY60-6583, each coupled to an engineered G protein. The structures reveal conserved orthosteric binding pockets with subtle differences, whereas the selectivity or specificity can mainly be attributed to regions extended from the orthosteric pocket. We also found that BAY60-6583 occupies a secondary pocket, where residues V250 and N273 were two key determinants for its selectivity against AR. This study offers a better understanding of ligand selectivity for the adenosine receptor family and provides a structural template for further development of AR ligands for related diseases.

摘要

人源腺苷 A 受体(AR)是一种 A 类 G 蛋白偶联受体,参与体内多个主要的生理和病理过程。AR 以相对较低的亲和力识别其配体腺苷和 NECA,但配体识别和信号转导的详细机制仍不清楚。在这里,我们通过冷冻电镜技术确定了与激动剂 NECA 和 BAY60-6583 结合的 AR 的两种结构,每种结构都与一种工程化的 G 蛋白偶联。这些结构揭示了保守的正位结合口袋,存在细微差异,而选择性或特异性主要归因于从正位口袋延伸出来的区域。我们还发现 BAY60-6583 占据了一个次要口袋,其中 V250 和 N273 两个残基是其对 AR 选择性的关键决定因素。这项研究为腺苷受体家族的配体选择性提供了更好的理解,并为进一步开发用于相关疾病的 AR 配体提供了结构模板。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/9e3b161172ec/sciadv.add3709-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/cceab2ec68d6/sciadv.add3709-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/8668d0469984/sciadv.add3709-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/715721d865e4/sciadv.add3709-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/b8cf7ba16d7a/sciadv.add3709-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/9e3b161172ec/sciadv.add3709-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/cceab2ec68d6/sciadv.add3709-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/8668d0469984/sciadv.add3709-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/715721d865e4/sciadv.add3709-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/b8cf7ba16d7a/sciadv.add3709-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80c/9788782/9e3b161172ec/sciadv.add3709-f5.jpg

相似文献

1
Cryo-EM structure of the human adenosine A receptor-G signaling complex.人源腺苷 A 受体-G 信号复合物的冷冻电镜结构。
Sci Adv. 2022 Dec 23;8(51):eadd3709. doi: 10.1126/sciadv.add3709.
2
Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A receptors.结构洞察 AB928 对腺苷 A 受体的双重拮抗作用机制。
Sci China Life Sci. 2024 May;67(5):986-995. doi: 10.1007/s11427-023-2459-8. Epub 2024 Jan 31.
3
Cryo-EM structure of the adenosine A receptor coupled to an engineered heterotrimeric G protein.冷冻电镜结构解析腺苷 A 受体与工程化异源三聚体 G 蛋白偶联。
Elife. 2018 May 4;7:e35946. doi: 10.7554/eLife.35946.
4
A novel and selective fluorescent ligand for the study of adenosine A receptors.一种新型、选择性的荧光配体,用于研究腺苷 A 受体。
Pharmacol Res Perspect. 2024 Aug;12(4):e1223. doi: 10.1002/prp2.1223.
5
Ligand-specific binding and activation of the human adenosine A(2B) receptor.配体特异性结合和激活人腺苷 A(2B)受体。
Biochemistry. 2013 Jan 29;52(4):726-40. doi: 10.1021/bi3012065. Epub 2013 Jan 14.
6
On the G protein-coupling selectivity of the native A adenosine receptor.内源性 A 腺苷受体的 G 蛋白偶联选择性。
Biochem Pharmacol. 2018 May;151:201-213. doi: 10.1016/j.bcp.2017.12.003. Epub 2017 Dec 7.
7
Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts.增强或沉默心脏成纤维细胞中腺苷A2b受体的功能效应。
Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2478-86. doi: 10.1152/ajpheart.00217.2004. Epub 2004 Jul 29.
8
BAY60-6583 acts as a partial agonist at adenosine A2B receptors.BAY60-6583 在腺苷 A2B 受体上作为部分激动剂起作用。
J Pharmacol Exp Ther. 2014 Jun;349(3):427-36. doi: 10.1124/jpet.113.210849. Epub 2014 Mar 14.
9
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.B16黑色素瘤中A2B腺苷受体的激活诱导FAP阳性肿瘤基质细胞中CXCL12的表达,促进肿瘤进展。
Oncotarget. 2016 Sep 27;7(39):64274-64288. doi: 10.18632/oncotarget.11729.
10
Stimulation of gastric acid secretion by rabbit parietal cell A(2B) adenosine receptor activation.兔壁细胞A(2B)腺苷受体激活对胃酸分泌的刺激作用。
Am J Physiol Cell Physiol. 2015 Dec 15;309(12):C823-34. doi: 10.1152/ajpcell.00224.2015. Epub 2015 Oct 14.

引用本文的文献

1
Molecular basis of ligand binding and receptor activation at the human A adenosine receptor.人类A1腺苷受体配体结合及受体激活的分子基础
Nat Commun. 2025 Aug 18;16(1):7674. doi: 10.1038/s41467-025-62872-x.
2
Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.CD73-腺苷信号通过肿瘤微环境调控肝细胞癌的研究进展
J Exp Clin Cancer Res. 2025 May 26;44(1):161. doi: 10.1186/s13046-025-03416-5.
3
Cryo-EM structure of an activated GPR4-Gs signaling complex.活化的GPR4-Gs信号复合物的冷冻电镜结构

本文引用的文献

1
Crystal structure of a constitutive active mutant of adenosine A receptor.腺苷A受体组成型活性突变体的晶体结构
IUCrJ. 2022 Mar 17;9(Pt 3):333-341. doi: 10.1107/S2052252522001907. eCollection 2022 May 1.
2
Structure-based discovery of nonhallucinogenic psychedelic analogs.基于结构的非致幻迷幻剂类似物的发现。
Science. 2022 Jan 28;375(6579):403-411. doi: 10.1126/science.abl8615. Epub 2022 Jan 27.
3
Structural perspective of class B1 GPCR signaling.B1 类 G 蛋白偶联受体信号的结构视角。
Nat Commun. 2025 Jan 11;16(1):605. doi: 10.1038/s41467-025-55901-2.
4
Ligand and Residue Free Energy Perturbations Solve the Dual Binding Mode Proposal for an AAR Partial Agonist.配体和残基自由能扰动解决了AAR部分激动剂的双重结合模式问题。
J Phys Chem B. 2025 Jan 23;129(3):886-899. doi: 10.1021/acs.jpcb.4c07391. Epub 2025 Jan 8.
5
Hypoxia-adenosinergic regulation of B cell responses.低氧-腺苷能调节 B 细胞反应。
Front Immunol. 2024 Nov 4;15:1478506. doi: 10.3389/fimmu.2024.1478506. eCollection 2024.
6
Structural insights into the agonist selectivity of the adenosine A receptor.腺苷 A 受体激动剂选择性的结构见解。
Nat Commun. 2024 Nov 7;15(1):9294. doi: 10.1038/s41467-024-53473-1.
7
A novel and selective fluorescent ligand for the study of adenosine A receptors.一种新型、选择性的荧光配体,用于研究腺苷 A 受体。
Pharmacol Res Perspect. 2024 Aug;12(4):e1223. doi: 10.1002/prp2.1223.
8
-Acyl--Alkyl Sulfonamide Probes for Ligand-Directed Covalent Labeling of GPCRs: The Adenosine A Receptor as Case Study.酰基-烷基磺酰胺探针用于配体定向的 GPCR 共价标记:以腺苷 A 受体为例。
ACS Chem Biol. 2024 Jul 19;19(7):1554-1562. doi: 10.1021/acschembio.4c00210. Epub 2024 Jun 26.
9
NECA alleviates inflammatory responses in diabetic retinopathy through dendritic cell toll-like receptor signaling pathway.NECA 通过树突状细胞 Toll 样受体信号通路减轻糖尿病视网膜病变的炎症反应。
Front Immunol. 2024 Jun 4;15:1415004. doi: 10.3389/fimmu.2024.1415004. eCollection 2024.
10
A adenosine receptor signaling and regulation.A 腺苷受体信号传导与调节。
Purinergic Signal. 2025 Apr;21(2):201-220. doi: 10.1007/s11302-024-10025-y. Epub 2024 Jun 4.
Trends Pharmacol Sci. 2022 Apr;43(4):321-334. doi: 10.1016/j.tips.2022.01.002. Epub 2022 Jan 22.
4
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models.AlphaFold 蛋白质结构数据库:用高精度模型极大地扩展蛋白质序列空间的结构覆盖范围。
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444. doi: 10.1093/nar/gkab1061.
5
Adenosine receptor antagonists: Recent advances and therapeutic perspective.腺苷受体拮抗剂:最新进展与治疗前景。
Eur J Med Chem. 2022 Jan 5;227:113907. doi: 10.1016/j.ejmech.2021.113907. Epub 2021 Oct 13.
6
Positive allosteric mechanisms of adenosine A receptor-mediated analgesia.腺苷 A 受体介导的镇痛的正变构机制。
Nature. 2021 Sep;597(7877):571-576. doi: 10.1038/s41586-021-03897-2. Epub 2021 Sep 8.
7
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
8
Identification of V6.51L as a selectivity hotspot in stereoselective A adenosine receptor antagonist recognition.鉴定 V6.51L 为立体选择性 A 腺苷受体拮抗剂识别的选择性热点。
Sci Rep. 2021 Jul 8;11(1):14171. doi: 10.1038/s41598-021-93419-x.
9
Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy.冷冻电镜结构解析揭示 VIP1 受体-G 蛋白复合物的激活状态 通过 NanoBiT 连接策略。
Nat Commun. 2020 Aug 17;11(1):4121. doi: 10.1038/s41467-020-17933-8.
10
Characterization of cancer-related somatic mutations in the adenosine A receptor.腺苷 A 受体中与癌症相关的体细胞突变的特征。
Eur J Pharmacol. 2020 Aug 5;880:173126. doi: 10.1016/j.ejphar.2020.173126. Epub 2020 Apr 26.